Skip to content
Screener

Amgen AMGN Net Income

Net Income at other companies

Eli Lilly logo
Eli LillyLLY
$7.1B+25.3%
Pfizer logo
PfizerPFE
-$248M-109%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$1.3B-6.8%
Nektar Therapeutics logo
Nektar TherapeuticsNKTR
-$40.62M+2.3%
Oruka Therapeutics, Inc. logo
Oruka Therapeutics, Inc.ORKA
-$31.82M-51.5%
Rigel Pharmaceuticals logo
Rigel PharmaceuticalsRIGL
$8.65M-24.4%

Segments

By segment

See full
Reportable Segment$2.38B+65.9%

Other financials

Income statement

See full
Revenue$10.1B+9.5%
Gross profit$7.2B+17.4%
Operating income$3.5B+32.3%
EPS (diluted)$4.37+64.9%

Balance sheet

See full
Cash & equivalents$574.0M+5.9%
Total debt$57.3B+2.0%
Total equity$11.7B+57.4%
Total assets$95.6B+8.8%

Cash flow

See full
Operating cash flow$4.0B+75.5%
CapEx$513.0M+39.0%
Free cash flow$3.5B+82.6%

Valuation

See full
Market cap$238.06B+53.6%
Enterprise value$294.79B+39.9%
P/E27.2×+3.8×
P/S6.3×+1.8×

Profitability

See full
Gross margin69.5%+5.0pp
Operating margin30%+6.5pp
Net margin23%+4.0pp
FCF margin26.7%-3.7pp

Returns & leverage

See full
Return on equity91.5%-7.7pp
Debt / equity4.9×-2.7×
Current ratio1.4×+0.1×

Where this comes from

Reported directly by Amgen in its filing.

Tagged under the XBRL concept us-gaap:NetIncomeLoss.

The source filing: Amgen’s 10-Q, filed August 5, 2026.

Filed
Aug 4, 2026, 8:00 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0000318154-26-000126
Line itemThree months ended June 30, 2026Three months ended June 30, 2025Six months ended June 30, 2026Six months ended June 30, 2025
Other (expense) income, net(73)(394)21,124
Income before income taxes2,7681,5684,8523,541
Provision for income taxes393136658379
Net income$2,375$1,432$4,194$3,162
Earnings per share:
Basic$4.40$2.66$7.77$5.88
Diluted$4.37$2.65$7.71$5.84
Weighted-average shares used in calculation of earnings per share:

Item 1. FINANCIAL STATEMENTS

FAQ

What is Amgen's net income?
Amgen (AMGN) reported net income of $2.38B in Q2 2026.
How has Amgen's net income changed year-over-year?
Amgen's net income increased by 65.9% year-over-year, from $1.43B to $2.38B.
What is the long-term trend for Amgen's net income?
Over 4 years (2021 to 2025), Amgen's net income has grown at a 7.0% compound annual growth rate (CAGR), from $5.89B to $7.71B.
What does net income mean?
The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.

Ask your AI about Amgen's net income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude